[Federal Register Volume 88, Number 33 (Friday, February 17, 2023)]
[Notices]
[Pages 10339-10340]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03320]



[[Page 10339]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-23-0920; Docket No. CDC-2023-0009]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a continuing information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled Data Collection Through Web Based Surveys for Evaluating Act 
Against AIDS Social Marketing Campaign Phases Targeting Consumers. This 
project which includes web surveys to test campaign messaging.

DATES: CDC must receive written comments on or before April 18, 2023.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0009 by either of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Data Collection Through Web Based Surveys for Evaluating Act 
Against AIDS Social Marketing Campaign Phases Targeting Consumers (OMB 
Control No. 0920-0920, Exp. 5/31/2023)--Extension--National Center for 
HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    In response to the continued HIV epidemic in our country, CDC 
launched the Let's Stop HIV Together campaign (formerly known as Act 
Against AIDS), a multifaceted communication campaign to reduce HIV 
incidence in the United States in 2009. CDC has released the campaign 
in phases, with some of the phases running concurrently. Each phase of 
the campaign uses mass media and direct-to-consumer channels to deliver 
messages. Some campaigns provide basic education and increase awareness 
of HIV/AIDS among the general public whereas others emphasize HIV 
prevention and testing among specific subgroups or communities at 
greatest risk of infection. CDC will also develop new messages to 
address changes in prevention science and subpopulations affected by 
HIV. The proposed study will assess the effectiveness of these social 
marketing messages aimed at increasing HIV/AIDS awareness, increasing 
prevention behaviors, and improving HIV testing rates among consumers.
    This Extension of an ongoing study will allow for continued 
evaluation of the effectiveness of Let's Stop HIV Together social 
marketing campaign through surveys with consumers. A total of 6,445 
respondents were approved for the previously renewed Generic ICR (0920-
0920) in 2022, and since the approval date, 2,500 respondents were 
surveyed under the GenIC, ``Development of Messages for the Let's Stop 
HIV Together National Campaign''. The information collected from this 
survey was used to evaluate the acceptability and potential 
effectiveness of proposed concepts, messages, and taglines for a 
component of the Let's Stop HIV Together campaign focused on HIV 
prevention that promotes proven, effective prevention strategies, such 
as pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP). 
We are requesting a three-year Extension to continue surveying target 
audiences.
    Through this Extension, we plan to reach the remaining approved 
3,945 respondents. To obtain the remaining respondents, we anticipate 
screening approximately 26,336 individuals. Depending on the target 
audience for the campaign phase, the study screener will vary. The 
study screener may address one or more of the following items: Race/
ethnicity, sexual behavior, sexual orientation, gender identity, HIV 
testing history, HIV status, and injection drug use. Each survey will 
have a core set of items asked in all rounds, as well as a module of 
questions relating to specific Let's Stop HIV Together phases and 
activities.
    Respondents will be recruited through national opt-in email lists, 
the internet, and external partnerships with community-based and 
membership organizations that work with or represent individuals from 
targeted populations (e.g., National Urban League, the National Medical 
Association). Respondents will self-administer the survey at home on

[[Page 10340]]

personal computers. CDC requests OMB approval for an estimated 2,849 
annual burden hours. There is no cost to the respondents other than 
their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                       Average
                                                        Number of       Number of     burden per   Total burden
       Type of respondent             Form name        respondents    responses per    response       (in hr)
                                                                       respondent      (in hr)
----------------------------------------------------------------------------------------------------------------
Individuals (male and female)    Study Screener....          26,336               1         2/60             877
 aged 18 years and older.
                                 Survey Module.....           3,945               1        30/60           1,972
                                                    ------------------------------------------------------------
    Total......................  ..................  ..............  ..............  ...........           2,849
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2023-03320 Filed 2-16-23; 8:45 am]
BILLING CODE 4163-18-P